-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on NOV, Lowers Price Target to $20

Benzinga·07/31/2026 12:10:24
Listen to the news
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and lowers the price target from $21 to $20.